Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01409811
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:42.777092+00:00
Published At
2020-04-28T00:00:00+00:00
Record Updated At
2020-05-08
Results Posted At
2020-04-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Estrogen Receptor-positive Breast Cancer", "Invasive Ductal Breast Carcinoma", "Progesterone Receptor-positive Breast Cancer", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage IIA Breast Cancer", "Stage IIB Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-05-08"
protocolSection.identificationModule.nctId
"NCT01409811"
protocolSection.identificationModule.officialTitle
"A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-04-28"

Study condition terms

  • Estrogen Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Invasive Ductal Breast Carcinoma (protocolSection.conditionsModule.conditions)
  • Progesterone Receptor-positive Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IA Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IB Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIA Breast Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIB Breast Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.